INHALED IMATINIB FOR PULMONARY ARTERIAL HYPERTENSION CLINICAL TRIAL: DESIGN OF THE IMPACT PHASE 2B/3 STUDY DESIGN

被引：1
|
作者：
Gillies, Hunter
Chakinala, Murali M.
Dake, Ben
Feldman, Jeremy P.
Hoeper, Marius M.
Humbert, Marc
Jing, Zhi-Cheng
Langley, Jonathan
McLaughlin, Vallerie
Niven, Ralph
Rosenkranz, Stephan H.
Zhang, Xiaosha
Hill, Nicholas S.
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1923
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2325A / 2329A
页数：5
相关论文
共 50 条
  • [31] Tropifexor in Combination with Cenicriviroc: Pharmacokinetics and Clinical Safety in Healthy Volunteers PLUS Study Design of a Phase 2B Trial in Patients with Nonalcoholic Steatohepatitis
    Stringer, Rowan
    Gu, Jessie
    Pedrosa, Marcos C.
    Woessner, Ralph
    Ayalasomayajula, Surya
    Seyedkazemi, Star
    Chen, Jin
    Fischer, Laurent
    Vaidyanathan, Sujata
    Anstee, Quentin M.
    HEPATOLOGY, 2018, 68 : 991A - 991A
  • [32] Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial
    Sitbon, Olivier
    Skride, Andris
    Feldman, Jeremy
    Sahay, Sandeep
    Shlobin, Oksana A.
    Mclaughlin, Vallerie
    Ghofrani, Hossein-Ardeschir
    Langleben, David
    Parsley, Ed
    D'Souza, Gwyn
    Marmon, Tonya
    Kamau-Kelley, Watiri
    Jones, Renee
    Grewal, Ravi
    Wring, Steve
    Palacios, Michelle
    Naik, Himanshu
    Denning, Jill
    Lazarus, Howard M.
    Humbert, Marc
    LANCET RESPIRATORY MEDICINE, 2024, 12 (11): : 865 - 876
  • [33] Study Design of the Phase 3 ADVANCE Program Evaluating Time-to-Clinical Events and Exercise Capacity in Patients with Pulmonary Arterial Hypertension Treated with Ralinepag
    McLaughlin, V. V.
    Channick, R.
    Walsh, B.
    Keating, M.
    Gilder, K.
    Cabell, C.
    Klassen, P.
    Tapson, V. F.
    Humbert, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [34] Lasofoxifene Phase 2 and Phase 3 clinical trial design and strategy.
    Lee, A
    Radecki, D
    Wolter, K
    Proulx, J
    Buonanno, M
    Dillon, V
    Houck, T
    Orri, M
    Day, W
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S404 - S404
  • [35] Safety update on dapagliflozin across the phase 2b/3 clinical trial programme
    Scheen, A. J. L.
    Jabbour, S.
    Seufert, J.
    Bailey, C. J.
    Karup, C.
    Langkilde, A. M.
    DIABETOLOGIA, 2017, 60 : S419 - S419
  • [36] A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2)
    Lazarus, Howard M.
    Denning, Jill
    Wring, Stephen
    Palacios, Michelle
    Hoffman, Sidra
    Crizer, Katelyn
    Kamau-Kelley, Watiri
    Symonds, William
    Feldman, Jeremy
    PULMONARY CIRCULATION, 2022, 12 (02)
  • [37] BMPR2 mutation and clinical response to imatinib in a case of heritable pulmonary arterial hypertension
    Kumar, Shine
    Biswas, Lalitha
    Pushkaran, Anju Choorakottayil
    Kumar, Raman Krishna
    PULMONARY CIRCULATION, 2024, 14 (01)
  • [38] Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis
    Nathan, Steven D.
    Behr, Jurgen
    Cottin, Vincent
    Lancaster, Lisa
    Smith, Peter
    Deng, C. Q.
    Pearce, Natalie
    Bell, Heidi
    Peterson, Leigh
    Flaherty, Kevin R.
    BMJ OPEN RESPIRATORY RESEARCH, 2022, 9 (01)
  • [39] Study Design and Rationale for the TETON-PPF Clinical Trial of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis
    Nathan, S. D.
    Behr, J.
    Cottin, V.
    Lancaster, L. H.
    Smith, P.
    Rao, Y.
    Breytenbach, N.
    Bell, H.
    Peterson, L.
    Flaherty, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [40] AZD3427, a relaxin mimetic in pulmonary hypertension group 2 associated with left heart disease: design and rationale of the phase 2b Re-PHIRE Study
    Ufnal, M.
    Connolly, K.
    Guazzi, M.
    Bonderman, D.
    Ezekowitz, J.
    Gustafsson, F.
    Ciurzynski, M.
    Vilella, R. Lopez
    Tariq, A.
    Gardner, R.
    Jansa, P.
    Van Wijk, S.
    Kinugawa, K.
    Bjorklund, E.
    Rosenkranz, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 216 - 216
12345